Investigating a Training Supporting Shared Decision Making (ITS SDM)

Completed (inferred)Not a drug-phase studyMS (type not specified)ISRCTN78716079

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What it measured

Main measures

  • 1. Coefficient SDM-MASS of the MAPPIN'SDM inventory 2. Components of the coefficient SDM-MASS of the MAPPIN'SDM inventory in comparison to: 2.1. OPTION (observing patient involvement) scale 2.2. SDM-Q 2.3. Dyadic coding scales (DCS) 3. Coefficient ELAB composed from the QUiCC24 questionnaire 4. As it is considered important that the trial does not negatively affect the practice process by burden

    Thinking and memory

Other measures (1)

  • 1. Item characteristics of QUiCC24 for validation purposes (Cronbach's alpha) 2. Item difficulty 3. Item total correlations coefficients between different foci of MAPPIN'SDM (doctor, patient, observer scales)

Who could take part

MS (type not specified) · 18 to 75

Show the full criteria

Inclusion criteria

Inclusion: 1. Doctor - patient dyads facing a decision (between treatment or diagnostic options) within a encounter 2. Aged 18-75, male or female Exclusion: Less than two possible options to decide upon

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Background and study aims The process of medical decision making is a central focus of research on communication in health care. Nowadays, shared decision making (SDM) is regarded as the best practice model for this communicative challenge. In an SDM communication, the doctor and the patient exchange their knowledge about the treatment options, the medical evidence about their pros and cons, and the personal preferences of both participants. This should lead to a common, ‘shared’ decision between doctor and patient. Despite over 20 years of SDM research, the appropriate way of assessing both the quality of a physician’s – and a patient’s – SDM performance and the outcome of their effort is still to be defined. The aim of this study is to find out whether a video-based short training intervention increases the extent to which patients and their doctors cooperate in treatment decision making. Who can participate? Doctors and their patients aged 18-75 What does the study involve? Participating doctors are randomly allocated to undergo the training either straight away or after a waiting period. During the training the participating doctors each video-record four consultations with their patients. Between the four consultations each doctor receives video-based individual coaching sessions supported by a manual and a DVD to help them to improve their communication in terms of SDM. Doctors, patients and observers (watching the video tapes) complete questionnaires to assess the effects of the training. What are the possible benefits and risks of participating? This study should make it possible to assess SDM, to teach SDM, and to better understand the effect of SDM on patients. Where is the study run from? Kiel Cancer Centre (Tumorzentrum Kiel) (Germany) When is the study starting and how long is it expected to run for? June 2011 to April 2012 Who is funding the study? Kiel Cancer Centre (Tumorzentrum Kiel) (Germany) Who is the main contact? Dr Friedemann Geiger

Papers

Loading reviews and guidelines…

History

    1. Started

      Jun 2011

    2. Finished

      Apr 2012

    Assembled by software from public sources.